Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the only US FDA-approved medication for the treatment of gastroparesis. However, the FDA ...

Current research into effective treatments for gastroparesis is focused on agonists of motilin, a peptide hormone that accelerates gastric emptying. McCallum and colleagues studied whether ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025Gimoti remains only approved drug shown to ...

This may cause persistent nausea and vomiting. The symptoms include constant nausea and vomiting. → Common treatment options → Questions to ask your doctor Gastroparesis is said to be caused by ...

Most of the time, doctors say, gastroparesis will improve after stopping the medication. But some people say that their ...

(NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, underscores its ...

Unfortunately, Mounjaro and similar medications have caused some people to experience serious complications, including gastroparesis, or stomach paralysis. For some patients who have experienced ...

Evoke Pharma (EVOK) underscores its commitment to patients and healthcare providers managing gastroparesis in light of FDA’s recent update ...

(RTTNews) - Evoke Pharma Inc. (EVOK), a pharmaceutical company focused on treatments for gastrointestinal diseases, announced on Tuesday that it has received notices of allowance for two ...